Coronary revascularization and use of hemodynamic support in acute coronary syndromes

Cardiogenic shock develops in up to 10% of patients with acute myocardial infarction and continues to have high mortality. Early invasive treatment is the default therapeutic approach in these patients. On the basis of the results of the CULPRIT-SHOCK trial, culprit-only revascularization during the...

Full description

Saved in:
Bibliographic Details
Main Authors: Xenogiannis Iosif
Tajti Péter
Burke Nicholas M.
Chavez Ivan
Gössl Mario
Mooney Michael
Poulose Anil
Sorajja Paul
Traverse Jay
Wang Yale
Brilakis Emmanouil S.
Format: Article
Published: 2019
Series:HELLENIC JOURNAL OF CARDIOLOGY 60 No. 3
doi:10.1016/j.hjc.2019.01.010

mtmt:30594201
Online Access:http://publicatio.bibl.u-szeged.hu/17179
Description
Summary:Cardiogenic shock develops in up to 10% of patients with acute myocardial infarction and continues to have high mortality. Early invasive treatment is the default therapeutic approach in these patients. On the basis of the results of the CULPRIT-SHOCK trial, culprit-only revascularization during the acute phase is preferred over multivessel revascularization. Routine use of intra-aortic balloon pump (IABP) is not recommended; however, the use of mechanical circulatory support has been increasing despite limited observational data to support its use. Several studies support multivessel revascularization in patients with uncomplicated ST-segment elevation acute myocardial infarction and simple nonculprit lesions to improve subsequent clinical outcomes.
Physical Description:165-170
ISSN:1109-9666